Chris Francis - 26 Feb 2026 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Reporting relationship: SVP, Corporate Development, Head of Emerging Areas
Issuer ticker: WVE
Reported as of: 26 Feb 2026
Net transaction value: -$357,673
SEC form: 4
Accepted by SEC: 27 Feb 2026, 21:00:03 UTC
Prior SEC filing: 11 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Chris Francis

Key filing fact

Chris Francis filed Form 4 for Wave Life Sciences Ltd. (WVE) on 27 Feb 2026.

Key facts

This page summarizes Chris Francis's Form 4 filing for Wave Life Sciences Ltd. (WVE).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 27 Feb 2026, 21:00.

Change

Previous filing in this sequence was filed on 11 Feb 2026.
Current net transaction value: -$357,673.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001657709 Primary reporting owner

Francis Chris

Relationship: SVP, Corporate Development, Head of Emerging Areas
Address: C/O WAVE LIFE SCIENCES LTD.,, 733 CONCORD AVE., CAMBRIDGE
Signature: /s/ Chris Francis
Signature date: 27 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WVE transaction

Ordinary Shares

Options Exercise

Transaction value: $69,273
Shares: +17,900
Change %: +29%
Price: $3.87
Shares after: 79,767
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F1

WVE transaction

Ordinary Shares

Sale

Transaction value: $270,183
Shares: -17,900
Change %: -22%
Price: $15.09
Shares after: 61,867
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F1, F4

WVE transaction

Ordinary Shares

Options Exercise

Transaction value: $72,646
Shares: +15,294
Change %: +25%
Price: $4.75
Shares after: 77,161
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F1

WVE transaction

Ordinary Shares

Sale

Transaction value: $229,410
Shares: -15,294
Change %: -20%
Price: $15.00
Shares after: 61,867
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WVE transaction Derivative

Share Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -17,900
Change %: -11%
Price: $0.000000
Shares after: 143,200
Date: 26 Feb 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 17,900
Exercise price: $3.87
Footnotes: F2

WVE transaction Derivative

Share Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -15,294
Change %: -20%
Price: $0.000000
Shares after: 61,175
Date: 26 Feb 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 15,294
Exercise price: $4.75
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.

Footnote F2

The option vests as to 25% of the shares on February 5, 2025, and vests as to an additional 6.25% of the shares quarterly thereafter until February 5, 2028.

Footnote F3

The option vests as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027.

Footnote F4

The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $15.00 to $15.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC remarks

SVP, Corporate Development, Head of Emerging Areas